Maxcyte (MXCT) FCF Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -473.00 |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 8,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,025.00 |
| Mar 31, 2026 | -3,811.00 |
| Dec 31, 2025 | 18,238.00 |
| Sep 30, 2025 | -5,139.00 |
| Jun 30, 2025 | -2,302.00 |
| Mar 31, 2025 | 4,361.00 |
| Dec 31, 2024 | -14,224.00 |
| Sep 30, 2024 | 21,710.00 |
| Jun 30, 2024 | 276.00 |
| Mar 31, 2024 | -8,877.00 |
| Dec 31, 2023 | 31,749.00 |
| Sep 30, 2023 | -21,217.00 |
| Jun 30, 2023 | -16,814.00 |
| Mar 31, 2023 | -1,616.00 |
| Dec 31, 2022 | -27,769.00 |
| Sep 30, 2022 | -4,108.00 |
| Jun 30, 2022 | 15,024.00 |
| Mar 31, 2022 | 2,701.00 |
| Dec 31, 2021 | -2,250.00 |
| Sep 30, 2021 | 3,525.00 |